Literature DB >> 15160487

Upregulation of HARP during in vitro myogenesis and rat soleus muscle regeneration.

Danièle Caruelle1, Zohra Mazouzi, Irene Husmann, Jean Delbé, Arlette Duchesnay, Jean Gautron, Isabelle Martelly, José Courty.   

Abstract

Heparin affin regulatory peptide (HARP) is a heparin binding growth factor that belongs to a family of molecule whose biological function in myogenesis has been suspected without formal demonstration. In the present study, we investigated the expression and the distribution of HARP and its mRNA during soleus muscle regeneration using a crushed-induced regeneration model and also during differentiation of muscle satellite cells in primary cultures. We show that HARP mRNA and protein expression are increased during the regeneration process with a peak at day 5 after muscle crushing when new myotubes are formed. In situ hybridization and immunohistochemical studies showed that activated myoblasts expressed HARP at day two after crushing. Five days after muscle lesion, HARP is localised in newly formed myotubes as well as in prefused activated myoblasts. In regenerated myofibers, 15 days after crushing, expression of HARP was reduced. In vitro experiments using primary cultures of rat satellite cells indicated that HARP expression level increased during the differentiation process and peaked on fusion of myoblasts into myotubes. This is the first study demonstrating the presence of HARP in fusing myogenic cells suggests that this growth factor could play a function in myogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160487     DOI: 10.1023/b:jure.0000021387.92378.2e

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  38 in total

1.  Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.

Authors:  H J Yeh; Y Y He; J Xu; C Y Hsu; T F Deuel
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

2.  HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells.

Authors:  R Tatsumi; J E Anderson; C J Nevoret; O Halevy; R E Allen
Journal:  Dev Biol       Date:  1998-02-01       Impact factor: 3.582

3.  Involvement of nitric oxide system in experimental muscle crush injury.

Authors:  I Rubinstein; Z Abassi; R Coleman; F Milman; J Winaver; O S Better
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Role of HB-GAM (heparin-binding growth-associated molecule) in proliferation arrest in cells of the developing rat limb and its expression in the differentiating neuromuscular system.

Authors:  E Szabat; H Rauvala
Journal:  Dev Biol       Date:  1996-08-25       Impact factor: 3.582

5.  The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells.

Authors:  H B Peng; A A Ali; Z Dai; D F Daggett; E Raulo; H Rauvala
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

6.  Expression of HB-GAM (heparin-binding growth-associated molecules) in the pathways of developing axonal processes in vivo and neurite outgrowth in vitro induced by HB-GAM.

Authors:  H Rauvala; A Vanhala; E Castrén; R Nolo; E Raulo; J Merenmies; P Panula
Journal:  Brain Res Dev Brain Res       Date:  1994-06-17

7.  Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin.

Authors:  J Courty; M C Dauchel; D Caruelle; M Perderiset; D Barritault
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

8.  A quantitative test for copper using bicinchoninic acid.

Authors:  A J Brenner; E D Harris
Journal:  Anal Biochem       Date:  1995-03-20       Impact factor: 3.365

9.  Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide.

Authors:  K Laaroubi; J Delbé; F Vacherot; P Desgranges; M Tardieu; M Jaye; D Barritault; J Courty
Journal:  Growth Factors       Date:  1994       Impact factor: 2.511

10.  Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis.

Authors:  T A Mitsiadis; M Salmivirta; T Muramatsu; H Muramatsu; H Rauvala; E Lehtonen; M Jalkanen; I Thesleff
Journal:  Development       Date:  1995-01       Impact factor: 6.868

View more
  5 in total

1.  TGF-beta1 favors the development of fast type identity during soleus muscle regeneration.

Authors:  Philippe Noirez; Sandra Torres; José Cebrian; Onnik Agbulut; Juliette Peltzer; Gillian Butler-Browne; Dominique Daegelen; Isabelle Martelly; Angelica Keller; Arnaud Ferry
Journal:  J Muscle Res Cell Motil       Date:  2005-12-17       Impact factor: 2.698

2.  Decrease of MMP-9 activity improves soleus muscle regeneration.

Authors:  Malgorzata Zimowska; Krzysztof H Olszynski; Marta Swierczynska; Wladyslawa Streminska; Maria A Ciemerych
Journal:  Tissue Eng Part A       Date:  2012-04-20       Impact factor: 3.845

3.  Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity.

Authors:  Giulia Maria Camerino; Sabata Pierno; Antonella Liantonio; Michela De Bellis; Maria Cannone; Valeriana Sblendorio; Elena Conte; Antonietta Mele; Domenico Tricarico; Sara Tavella; Alessandra Ruggiu; Ranieri Cancedda; Yoshinobu Ohira; Daniela Danieli-Betto; Stefano Ciciliot; Elena Germinario; Dorianna Sandonà; Romeo Betto; Diana Conte Camerino; Jean-François Desaphy
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

4.  VEGF and pleiotrophin modulate the immune profile of breast cancer.

Authors:  Kristi D Lynn; Christina L Roland; Rolf A Brekken
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

5.  Tissue-Specific Gene Repositioning by Muscle Nuclear Membrane Proteins Enhances Repression of Critical Developmental Genes during Myogenesis.

Authors:  Michael I Robson; Jose I de Las Heras; Rafal Czapiewski; Phú Lê Thành; Daniel G Booth; David A Kelly; Shaun Webb; Alastair R W Kerr; Eric C Schirmer
Journal:  Mol Cell       Date:  2016-06-02       Impact factor: 17.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.